LORD, ABBETT & CO. LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 94 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.29 and the average weighting 0.3%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$23,788
+20.2%
1,197,182
+3.6%
0.08%
+15.5%
Q1 2023$19,791
+88.8%
1,155,338
+115.7%
0.07%
+86.8%
Q4 2022$10,482
-99.9%
535,588
+0.1%
0.04%
+22.6%
Q3 2022$8,538,000
+135.1%
534,949
+102.7%
0.03%
+138.5%
Q2 2022$3,632,000
-6.8%
263,931
+7.4%
0.01%
+30.0%
Q1 2022$3,897,000
-86.2%
245,692
-80.9%
0.01%
-84.4%
Q4 2021$28,139,000
-22.2%
1,289,005
+6.6%
0.06%
-25.6%
Q3 2021$36,154,000
-50.5%
1,209,568
-26.6%
0.09%
-51.1%
Q2 2021$73,011,000
-0.4%
1,648,471
-0.2%
0.18%
-5.9%
Q1 2021$73,308,000
-15.9%
1,652,194
+3.9%
0.19%
-18.7%
Q4 2020$87,198,000
+139.7%
1,590,052
-0.1%
0.23%
+98.3%
Q3 2020$36,379,000
+30.0%
1,591,395
+19.1%
0.12%
+18.4%
Q2 2020$27,978,000
+32.5%
1,336,722
-11.7%
0.10%
+4.3%
Q1 2020$21,111,000
-9.1%
1,513,354
+48.3%
0.09%
+22.1%
Q4 2019$23,228,000
+369.4%
1,020,534
+140.3%
0.08%
+352.9%
Q3 2019$4,948,000
-27.3%
424,713
-6.3%
0.02%
-22.7%
Q2 2019$6,802,000
+21.1%
453,480
+41.6%
0.02%
+15.8%
Q1 2019$5,619,000
+15.6%
320,361
-2.3%
0.02%
+5.6%
Q4 2018$4,861,000
-52.2%
327,953
-20.5%
0.02%
-35.7%
Q3 2018$10,162,000
+45.2%
412,736
+15.8%
0.03%
+40.0%
Q2 2018$6,998,000356,5140.02%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,812,491$234,534,00010.10%
TANG CAPITAL MANAGEMENT LLC 2,965,485$41,369,0005.81%
Ghost Tree Capital, LLC 650,000$9,068,0002.40%
Boxer Capital, LLC 1,466,051$20,451,0001.39%
Vivo Capital, LLC 860,648$12,006,0001.09%
Samsara BioCapital, LLC 128,197$1,788,0001.03%
Cormorant Asset Management, LP 1,568,550$21,881,0001.02%
Perceptive Advisors 2,189,010$30,537,0000.80%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,677,367$23,399,0000.74%
Eventide Asset Management 1,415,000$19,739,0000.64%
View complete list of ROCKET PHARMACEUTICALS INC shareholders